Receptor antibodies as novel therapeutics for diabetes

Research output: Contribution to journal › Journal article › Communication

Standard

Receptor antibodies as novel therapeutics for diabetes. / Ussar, Siegfried; Vienberg, Sara Gry; Kahn, C Ronald.

In: Science Translational Medicine, Vol. 3, No. 113, 14.12.2011, p. 113ps47.

Research output: Contribution to journal › Journal article › Communication

Harvard

Ussar, S, Vienberg, SG & Kahn, CR 2011, 'Receptor antibodies as novel therapeutics for diabetes', Science Translational Medicine, vol. 3, no. 113, pp. 113ps47. https://doi.org/10.1126/scitranslmed.3003447

APA

Ussar, S., Vienberg, S. G., & Kahn, C. R. (2011). Receptor antibodies as novel therapeutics for diabetes. Science Translational Medicine, 3(113), 113ps47. https://doi.org/10.1126/scitranslmed.3003447

Vancouver

Ussar S, Vienberg SG, Kahn CR. Receptor antibodies as novel therapeutics for diabetes. Science Translational Medicine. 2011 Dec 14;3(113):113ps47. https://doi.org/10.1126/scitranslmed.3003447

Author

Ussar, Siegfried ; Vienberg, Sara Gry ; Kahn, C Ronald. / Receptor antibodies as novel therapeutics for diabetes. In: Science Translational Medicine. 2011 ; Vol. 3, No. 113. pp. 113ps47.

Bibtex

@article{66d5a4a219cc4eee866401526cac8fbe,
title = "Receptor antibodies as novel therapeutics for diabetes",
abstract = "Antibodies to receptors can block or mimic hormone action. Taking advantage of receptor isoforms, co-receptors, and other receptor modulating proteins, antibodies and other designer ligands can enhance tissue specificity and provide new approaches to the therapy of diabetes and other diseases.",
keywords = "Animals, Antibodies, Monoclonal, Diabetes Mellitus, Type 2, Female, Fibroblast Growth Factors, Humans, Male, Receptor, Fibroblast Growth Factor, Type 1",
author = "Siegfried Ussar and Vienberg, {Sara Gry} and Kahn, {C Ronald}",
year = "2011",
month = dec,
day = "14",
doi = "10.1126/scitranslmed.3003447",
language = "English",
volume = "3",
pages = "113ps47",
journal = "Science Translational Medicine",
issn = "1946-6234",
publisher = "american association for the advancement of science",
number = "113",

}

RIS

TY - JOUR

T1 - Receptor antibodies as novel therapeutics for diabetes

AU - Ussar, Siegfried

AU - Vienberg, Sara Gry

AU - Kahn, C Ronald

PY - 2011/12/14

Y1 - 2011/12/14

N2 - Antibodies to receptors can block or mimic hormone action. Taking advantage of receptor isoforms, co-receptors, and other receptor modulating proteins, antibodies and other designer ligands can enhance tissue specificity and provide new approaches to the therapy of diabetes and other diseases.

AB - Antibodies to receptors can block or mimic hormone action. Taking advantage of receptor isoforms, co-receptors, and other receptor modulating proteins, antibodies and other designer ligands can enhance tissue specificity and provide new approaches to the therapy of diabetes and other diseases.

KW - Animals

KW - Antibodies, Monoclonal

KW - Diabetes Mellitus, Type 2

KW - Female

KW - Fibroblast Growth Factors

KW - Humans

KW - Male

KW - Receptor, Fibroblast Growth Factor, Type 1

U2 - 10.1126/scitranslmed.3003447

DO - 10.1126/scitranslmed.3003447

M3 - Journal article

C2 - 22174312

VL - 3

SP - 113ps47

JO - Science Translational Medicine

JF - Science Translational Medicine

SN - 1946-6234

IS - 113

ER -

ID: 128935132